{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:26:59Z","timestamp":1793978819007,"version":"4.8.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100016016","name":"Gilead UK and Ireland Corporate Contributions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1053\/j.gastro.2026.08.010","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:59:11Z","timestamp":1786978751000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimizing Liver Fibrosis Screening in the General Population by Refining the Target Group"],"prefix":"10.1053","author":[{"given":"Jimmy Che-To","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Lai-Hung","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2026.08.010_bib1","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMra2403308","article-title":"Noninvasive assessment of liver fibrosis","volume":"393","author":"Castera","year":"2025","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"10.1053\/j.gastro.2026.08.010_bib2","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.3350\/cmh.2024.0351","article-title":"Prevalence of clinically significant liver fibrosis in the general population: a systematic review and meta-analysis","volume":"30","author":"Kim","year":"2024","journal-title":"Clin Mol Hepatol"},{"key":"10.1053\/j.gastro.2026.08.010_bib3","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0140-6736(26)00354-5","article-title":"Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study","volume":"407","author":"Graupera","year":"2026","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2026.08.010_bib4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2337\/dci24-0094","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American Diabetes Association","volume":"48","author":"Cusi","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2026.08.010_bib5","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/hep4.1765","article-title":"Poor awareness of liver disease among adults with NAFLD in the United States","volume":"5","author":"Alqahtani","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2026.08.010_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.08.010_bib7","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2026.08.010_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.gastro.2026.01.047","article-title":"Clinical care pathway for the risk stratification and management of patients with metabolic dysfunction-associated steatotic liver disease","volume":"171","author":"Kanwal","year":"2026","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2026.08.010_bib9","first-page":"S59","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Care in Diabetes\u20142025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2026.08.010_bib10","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.08.010_bib11","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.cgh.2025.02.018","article-title":"Effectiveness of six international guidelines using Fibrosis-4 and FibroScan for risk stratification of metabolic dysfunction-associated steatotic liver disease in type 2 diabetes","volume":"23","author":"Vidal-Trecan","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.08.010_bib12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2337\/dc24-2075","article-title":"Screening for metabolic dysfunction-associated steatotic liver disease-related advanced fibrosis in diabetology: a prospective multicenter study","volume":"48","author":"Caussy","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2026.08.010_bib13","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2026.06.003","article-title":"Validated early detection metrics reduce the population requiring liver fibrosis screening","author":"van Kleef","year":"2026","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2026.08.010_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jhep.2025.01.014","article-title":"Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease","volume":"83","author":"Yip","year":"2025","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.08.010_bib15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.cgh.2024.02.008","article-title":"Degree of discordance between FIB-4 and transient elastography: an application of current guidelines on general population cohort","volume":"22","author":"Chang","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.08.010_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11606-024-08955-9","article-title":"Identifying and linking patients at risk for MASLD with advanced fibrosis to care in primary care","volume":"40","author":"Xiao","year":"2025","journal-title":"J Gen Intern Med"},{"key":"10.1053\/j.gastro.2026.08.010_bib17","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0140-6736(23)01174-1","article-title":"Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study","volume":"402","author":"Serra-Burriel","year":"2023","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2026.08.010_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S2468-1253(24)00274-7","article-title":"Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study","volume":"10","author":"Lindvig","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2026.08.010_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jhep.2025.04.019","article-title":"Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes","volume":"83","author":"Vaz","year":"2025","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2026.08.010_bib20","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S2468-1253(25)00188-8","article-title":"Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis","volume":"10","author":"Celsa","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526071672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508526071672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:58:02Z","timestamp":1793977082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508526071672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":20,"alternative-id":["S0016508526071672"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2026.08.010","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing Liver Fibrosis Screening in the General Population by Refining the Target Group","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2026.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2026.06.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}